🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Dementia of Alzheimer Type

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI) NCT04956549NA1 site📍 Baton Rouge Pennington Biomedical Research Center · Tests: Physical activity program, Successful Aging Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis NCT06339190n/a2 sites📍 Box Hill📍 Wantirna Monash University · Tests: Venepuncture A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation NCT05552157Phase 2, Phase 337 sites📍 Birmingham📍 La Jolla📍 Los Angeles Washington University School of Medicine · Tests: Remternetug (SC), Matching Placebo (Remternetug) Autonomic Involvement in Patient With Cognitive Decline NCT06292741NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Sudoscan Assess Fibrin in Brains With AD/ADRD NCT05336695Phase 1, Phase 21 site📍 Boston Massachusetts General Hospital · Tests: PET/MR Imaging, 64Cu-FBP8 Dynamic Light Scattering Ocular Measurement in the Detection of Dementia NCT06613971n/a1 site📍 Coconut Creek MD Stem Cells A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation NCT06647498Phase 2, Phase 337 sites📍 Birmingham📍 La Jolla📍 Los Angeles Washington University School of Medicine · Tests: Remternetug, Matching Placebo (Remternetug) Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type NCT07066826Phase 2, Phase 31 site📍 Beijing Wanbangde Pharmaceutical Group Co., LTD · Tests: Huperzine A Controlled-Release Tablets, Donepezil hydrochloride tablets, Huperzine A controlled-release tablets placebo… PROMIS and Mobility Evaluation in Sarcoma Patients NCT07227961n/a4 sites📍 Phoenix📍 Rochester📍 Calgary University of Calgary · Tests: Surgery NYSCF Scientific Discovery Biobank NCT06203106n/a1 site📍 New York New York Stem Cell Foundation Research Institute · Tests: Biological Sample Collection Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia NCT07251023Phase 312 sites📍 Kazan'📍 Moscow📍 Moscow Bigespas LTD · Tests: DMB-I (INN: Latrepirdine), Memantine Hydrochloride 20 MG, Placebo Using the EHR to Advance Genomic Medicine Across a Diverse Health System NCT06377033NA1 site📍 Philadelphia University of Pennsylvania · Tests: Behavioral nudge The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3) NCT05885295n/a1 site📍 London Imperial College London · Tests: MRI brain, Blood tests, cognitive assessments A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease NCT07688213Phase 220 sites📍 Long Beach📍 Oakland📍 Naples Sanofi · Tests: SAR448851, Placebo Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia NCT04240561NA2 sites📍 Chicago📍 Evanston Northwestern University · Tests: High level of signal manipulation, Low level of signal manipulation Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD) NCT06597942Phase 1, Phase 21 site📍 Los Angeles University of California, Los Angeles · Tests: TMS, Transcranial Magnetic Stimulation Sham Validation of a Digital Intervention to Rehabilitate Cognitive Resources NCT07064226NA1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: RICORDO, Treatment as Usual (TAU) Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study) NCT06965062NA1 site📍 Singapore Vincent Tay Khwee Soon · Tests: Deep cervical lymph node to venous bypass (DCLNV-BP) The Effect of Combination of Mediterranean Diet and Oleocanthal in Patients With Mild Cognitive Impairment NCT06705738NA2 sites📍 Thessaloniki📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: SUPOL, Dietary Pattern: MeDi Uppsala-Dalarna Dementia and Gait Project NCT05893524n/a2 sites📍 Falun📍 Uppsala Dalarna University · Tests: Timed Up-and-Go (TUG single-task), Timed Up-and-Go dual-task (TUGdt), Clinical functional assessment
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy